BlackRock’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
662,181
+44,312
+7% +$72.9K ﹤0.01% 4289
2025
Q4
$1.08M Buy
617,869
+118,466
+24% +$261K ﹤0.01% 4288
2025
Q3
$1.17M Sell
499,403
-38,225
-7% -$73.2K ﹤0.01% 4246
2025
Q2
$1.09M Sell
537,628
-1,780,852
-77% -$3.41M ﹤0.01% 4224
2025
Q1
$3.78M Buy
2,318,480
+409,969
+21% +$823K ﹤0.01% 3752
2024
Q4
$3.49M Buy
1,908,511
+22,916
+1% +$101K ﹤0.01% 3860
2024
Q3
$10.9M Buy
1,885,595
+179,175
+11% +$1.48M ﹤0.01% 3357
2024
Q2
$13.8M Buy
1,706,420
+1,366,734
+402% +$14.4M ﹤0.01% 3193
2024
Q1
$4.71M Buy
339,686
+11,972
+4% +$103K ﹤0.01% 3693
2023
Q4
$2.01M Sell
327,714
-165,548
-34% -$817K ﹤0.01% 4039
2023
Q3
$2.3M Sell
493,262
-13,957
-3% -$77.1K ﹤0.01% 3945
2023
Q2
$2.72M Sell
507,219
-1,427,853
-74% -$11.5M ﹤0.01% 3930
2023
Q1
$19M Sell
1,935,072
-5,271
-0.3% -$89.9K ﹤0.01% 3002
2022
Q4
$36.3M Buy
1,940,343
+144,950
+8% +$3.29M ﹤0.01% 2689
2022
Q3
$37.2M Buy
1,795,393
+134,926
+8% +$3.45M ﹤0.01% 2672
2022
Q2
$34.5M Buy
1,660,467
+156,559
+10% +$4.41M ﹤0.01% 2743
2022
Q1
$64.8M Sell
1,503,908
-16,502
-1% -$743K ﹤0.01% 2420
2021
Q4
$91M Sell
1,520,410
-10,394
-0.7% -$833K ﹤0.01% 2275
2021
Q3
$132M Buy
1,530,804
+16,496
+1% +$1.66M ﹤0.01% 2029
2021
Q2
$168M Buy
1,514,308
+54,720
+4% +$5.26M ﹤0.01% 1902
2021
Q1
$163M Buy
1,459,588
+272,676
+23% +$35.9M ﹤0.01% 1865
2020
Q4
$126M Buy
1,186,912
+44,230
+4% +$5.89M ﹤0.01% 1931
2020
Q3
$159M Sell
1,142,682
-5,958
-0.5% -$1.24M 0.01% 1578
2020
Q2
$371M Buy
1,148,640
+429,716
+60% +$69M 0.01% 898
2020
Q1
$64.2M Buy
718,924
+82,707
+13% +$5.1M ﹤0.01% 1916
2019
Q4
$25.2M Sell
636,217
-14,982
-2% -$451K ﹤0.01% 2751
2019
Q3
$16M Buy
651,199
+8,797
+1% +$267K ﹤0.01% 2942
2019
Q2
$22.7M Buy
642,402
+27,946
+5% +$1.11M ﹤0.01% 2781
2019
Q1
$27.5M Buy
614,456
+10,129
+2% +$511K ﹤0.01% 2590
2018
Q4
$29M Buy
604,327
+24,382
+4% +$1.48M ﹤0.01% 2528
2018
Q3
$38.7M Buy
579,945
+9,500
+2% +$529K ﹤0.01% 2516
2018
Q2
$26.8M Buy
570,445
+29,676
+5% +$1.64M ﹤0.01% 2697
2018
Q1
$30.6M Sell
540,769
-11,523
-2% -$624K ﹤0.01% 2533
2017
Q4
$27.4M Sell
552,292
-4,963
-0.9% -$308K ﹤0.01% 2617
2017
Q3
$42.4M Buy
557,255
+101,479
+22% +$7.55M ﹤0.01% 2381
2017
Q2
$42.9M Buy
455,776
+12,776
+3% +$1.09M ﹤0.01% 2350
2017
Q1
$35.2M Buy
443,000
+442,451
+80,592% +$35.3M ﹤0.01% 2432
2016
Q4
$46K Sell
549
-77
-12% -$6.96K ﹤0.01% 2971
2016
Q3
$71K Buy
626
+65
+12% +$7.18K ﹤0.01% 2789
2016
Q2
$62K Buy
561
+159
+40% +$19.3K ﹤0.01% 2826
2016
Q1
$42K Sell
402
-100
-20% -$7.72K ﹤0.01% 2454
2015
Q4
$41K Buy
502
+394
+365% +$31.4K ﹤0.01% 2172
2015
Q3
$8K Hold
108
﹤0.01% 2827
2015
Q2
$11K Sell
108
-12
-10% -$1.28K ﹤0.01% 2720
2015
Q1
$12K Hold
120
﹤0.01% 2631
2014
Q4
$13K Hold
120
﹤0.01% 2597
2014
Q3
$14K Hold
120
﹤0.01% 2532
2014
Q2
$16K Buy
120
+117
+3,900% +$13.8K ﹤0.01% 2499
2014
Q1
$0 Buy
+3
New +$431 ﹤0.01% 3143

Other funds holding INO